Leidos · 15 hours ago
Biomedical Life Scientist
Leidos is a prominent organization in the health and services sector, and they are seeking a Biomedical Life Scientist to support the Congressionally Directed Medical Research Programs (CDMRP). The role involves planning scientific meetings, recruiting participants, and providing scientific notetaking support, all aimed at transforming healthcare through impactful research.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Plan and execute a variety of scientific meetings
Recruit scientists, clinicians, and consumer advocates to participate in scientific meetings
Develop and track schedules for tasks and deliverables
Provide scientific notetaking support by recording critical information from scientific meetings and writing comprehensive meeting reports
Draft scientific materials, including meeting summaries and funding opportunities
Conduct analyses of funding portfolio data and research outcomes and assembling data to prepare tables, graphs, and slides
Qualification
Required
Master's degree from an accredited college or university in biology, life sciences, or a related discipline, with 1+ years of related experience
U.S. citizenship is required per Contract to obtain a U.S. Department of Defense Public Trust security clearance
Strong interpersonal, written, and oral communication skills
Strong scientific writing skills
Exceptional attention to detail
Excellent organizational and time management skills
Proficiency with Microsoft Word, Excel, and PowerPoint
Experience using IT data management systems
Benefits
Leidos Life promotes excellent work-life balance.
This position is eligible for partial remote work and a flexible work schedule.
Leidos offers many opportunities for career development and advancement.
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase